Browse EX-10 agreements

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of June 25, 2026, between FibroBiologics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and/or Rule 506 of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

DEFINITIONS

1.1

…

EXHIBIT 10.2

REGISTRATION RIGHTS AGREEMENT

 

This Registration Rights Agreement (this “Agreement”) is made and entered into as of June [●], 2026, by and between FibroBiologics, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

 

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).

 

The Company and each Purchaser hereby agree as follows:

 

1. Definitions.

 

Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

 

“Advice” shall have the meaning set forth in Section 6(c).

…

AMENDMENT NO. 3 TO SYNERGY CHC CORP. 2024 EQUITY INCENTIVE PLAN

WHEREAS, Synergy CHC Corp. (the “Company”) previously established the 2024 Equity Incentive Plan of the Company (the “Plan”); and

WHEREAS, Section 13(a) of the Plan permits the Board of Directors of the Company to amend the Plan as set forth herein, subject to the approval of the Company’s stockholders as required by applicable law;

WHEREAS, the Board of Directors and the Company’s stockholders have approved this amendment as required by applicable law and the Company’s governing documents.

NOW, THEREFORE, the Plan is hereby amended, effective as of June 29, 2026, as follows:

 

Section 5(b) is hereby deleted and replaced with the following (the “Amendment”):

 

“Subject to Section 12 of the Plan, the Committee is authorized to deliver under the Plan an aggregate of one hundred fifty million (150,000,000) shares of Common Stock, all of which may be issued pursuant to the exercise of Incentive Stock Options.”

 

…

EXECUTION VERSION

 

June 23, 2026

 

GPIF I Funding 

as Borrower 

c/o Golub Capital Private Income Fund I 

200 Park Avenue, 25th Floor 

New York, New York 10166

 

Golub Capital Private Income Fund I 

as Servicer 

200 Park Avenue, 25th Floor New York, New York 10166

 

Re: Credit Agreement Side Letter

 

We refer to the Amended and Restated Credit Agreement, dated as of December 31, 2025 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among GPIF I Funding, as borrower (“Borrower”, “we” or “us”), the lenders from time to time party thereto, Bank of America, N.A. (“Bank of America” or “you”), as administrative agent, Golub Capital Private Income Fund I, as servicer, Computershare Trust Company, N.A., as collateral custodian, and Bank of America, N.A., as sole lead arranger and sole book manager. All terms used but not otherwise defined herein shall have the meanings set forth in the Credit Agreement. This letter amends and restates in its entirety that certain letter agreement re: Credit Agreement Side Letter

…

EXECUTION VERSION

 

June 23, 2026

 

GPIF S Funding

as Borrower

c/o Golub Capital Private Income Fund S

200 Park Avenue, 25th Floor

New York, New York 10166

 

Golub Capital Private Income Fund S

as Servicer

200 Park Avenue, 25th Floor New York, New York 10166

 

Re: Credit Agreement Side Letter

 

We refer to the Amended and Restated Credit Agreement, dated as of December 31, 2025 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among GPIF S Funding, as borrower (“Borrower”, “we” or “us”), the lenders from time to time party thereto, Bank of America, N.A. (“Bank of America” or “you”), as administrative agent, Golub Capital Private Income Fund S, as servicer, Computershare Trust Company, N.A., as collateral custodian, and Bank of America, N.A., as sole lead arranger and sole book manager. All terms used but not otherwise defined herein shall have the meanings set forth in the Credit Agreement. This letter amends and restates in its entirety that certain letter agreement re: Credit Agreement Side Letter dated

…

IMMUNIC, INC.

2019 OMNIBUS EQUITY INCENTIVE PLAN, AS AMENDED ON JUNE 28, 2023, MARCH 4, 2024, JUNE 4, 2025, AND JUNE 29, 2026

 

 

 

 

TABLE OF CONTENTS

 

 

 PAGE

 

Article 1. Effective Date, Objectives and Duration

1

1.1

Effective Date of the Plan

1

1.2

Objectives of the Plan

1

1.3

Duration of the Plan

1

Article 2. Definitions

1

2.1

“Affiliate”

1

2.2

“Award”

1

2.3

“Award Agreement”

1

2.4

“Board”

2

2.5

“Bonus Shares”

2

2.6

“Cause”

2

2.7

“CEO”

2

2.8

“Change in Control”

2

2.9

“Code”

2

2.10

“Committee” or “Incentive Plan Committee”

2

2.11

“Compensation Committee”

2

2.12

“Common Stock”

2

2.13

“Corporate Transaction”

2

2.14

“Deferred Stock”

2

2.15

“Disability” or “Disabled”

2

2.16

“Dividend Equivalent”

3

2.17

“Effective Date”

3

2.18

“Eligible Person”

3

2.19

“Exchange Act”

3

2.20

“Exercise Price”

3

2.21

“Fair Market Value”

3

2.22

“Grant Date”

4

2.23

“Grantee”

4

2.24

“Incentive Stock Option”

4

2.25

“Including” or “includes”

4

2.26

“Management Committee”

4

2.27

…

Execution Version

 

INDEMNIFICATION AGREEMENT

 

This Agreement, made and entered into effective as of June 24, 2026 (“Agreement”), by and between Alpex Acquisition Corporation, a Cayman Islands exempted company (“Company”), and the undersigned indemnitee (“Indemnitee”).

 

WHEREAS, the adoption of the Sarbanes-Oxley Act of 2002 and other laws, rules and regulations being promulgated have increased the potential for liability of officers and directors; and

 

WHEREAS, the board of directors of the Company (“Board”) has determined that the ability to attract and retain such persons is in the best interests of the Company’s shareholders; and

 

WHEREAS, it is reasonable, prudent and necessary for the Company to obligate itself contractually to indemnify, hold harmless, exonerate and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that such persons will serve or continue to serve the Company free from undue concern that they will not be adequately indemnified; and

…

Execution Version

 

INDEMNIFICATION AGREEMENT

 

This Agreement, made and entered into effective as of June 24, 2026 (“Agreement”), by and between Alpex Acquisition Corporation, a Cayman Islands exempted company (“Company”), and the undersigned indemnitee (“Indemnitee”).

 

WHEREAS, the adoption of the Sarbanes-Oxley Act of 2002 and other laws, rules and regulations being promulgated have increased the potential for liability of officers and directors; and

 

WHEREAS, the board of directors of the Company (“Board”) has determined that the ability to attract and retain such persons is in the best interests of the Company’s shareholders; and

 

WHEREAS, it is reasonable, prudent and necessary for the Company to obligate itself contractually to indemnify, hold harmless, exonerate and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that such persons will serve or continue to serve the Company free from undue concern that they will not be adequately indemnified; and

…

Execution Version

 

INDEMNIFICATION AGREEMENT

 

This Agreement, made and entered into effective as of June 24, 2026 (“Agreement”), by and between Alpex Acquisition Corporation, a Cayman Islands exempted company (“Company”), and the undersigned indemnitee (“Indemnitee”).

 

WHEREAS, the adoption of the Sarbanes-Oxley Act of 2002 and other laws, rules and regulations being promulgated have increased the potential for liability of officers and directors; and

 

WHEREAS, the board of directors of the Company (“Board”) has determined that the ability to attract and retain such persons is in the best interests of the Company’s shareholders; and

 

WHEREAS, it is reasonable, prudent and necessary for the Company to obligate itself contractually to indemnify, hold harmless, exonerate and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that such persons will serve or continue to serve the Company free from undue concern that they will not be adequately indemnified; and

…

Execution Version

 

SECURITIES TRANSFER AGREEMENT

 

This Securities Transfer Agreement is dated as of June 24, 2026 (this “Transfer”), by and among Hugreat Ltd, a British Virgin Islands company (the “Seller”), Alpex Acquisition Corporation, a Cayman Islands exempted company (the “Company”), and the parties identified on the signature page hereto (each a “Buyer” and collectively, the “Buyers”).

 

WHEREAS, on the terms and subject to the conditions set forth in this Transfer, the Seller wishes to transfer to the Buyers class B ordinary shares, $0.0001 par value (“Class B Ordinary Shares”) of the Company, a newly-organized blank check company, or special purpose acquisition company, formed for the purpose of effecting a merger, stock exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”), and the Buyers wish to purchase and receive such Initial Shares (as defined below) from the Seller.

…

Execution Version

 

INVESTMENT MANAGEMENT TRUST AGREEMENT

 

This Investment Management Trust Agreement (this “Agreement”) is made effective as of June 24, 2026, by and between Alpex Acquisition Corporation, a Cayman Islands corporation (the “Company”), and Equiniti Trust Company, LLC, a New York limited liability trust company (the “Trustee”).

 

WHEREAS, the Company’s registration statement on Form S-1 (File No. 333-294978) (the “Registration Statement”) and prospectus (the “Prospectus”), for its initial public offering of the Company’s units (the “Units”), each of which consists of one share of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), one warrant, each whole warrant entitling the holder to purchase one Ordinary Share (the “Warrants”), and one right to receive one-fourth (1/4) of an Ordinary Share upon the consummation of an initial business combination (such initial public offering hereinafter referred to as the “Offering”), has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission

…

Execution Version

 

INDEMNIFICATION AGREEMENT

 

This Agreement, made and entered into effective as of June 24, 2026 (“Agreement”), by and between Alpex Acquisition Corporation, a Cayman Islands exempted company (“Company”), and the undersigned indemnitee (“Indemnitee”).

 

WHEREAS, the adoption of the Sarbanes-Oxley Act of 2002 and other laws, rules and regulations being promulgated have increased the potential for liability of officers and directors; and

 

WHEREAS, the board of directors of the Company (“Board”) has determined that the ability to attract and retain such persons is in the best interests of the Company’s shareholders; and

 

WHEREAS, it is reasonable, prudent and necessary for the Company to obligate itself contractually to indemnify, hold harmless, exonerate and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that such persons will serve or continue to serve the Company free from undue concern that they will not be adequately indemnified; and

…